# Farmaqro, S.A. de C.V. – FDA Inspection, May 25, 2018

Source: https://www.keypedia.com/records/fda_inspections/farmaqro-sa-de-cv/7b3570be-eda4-4450-a03c-c2a0367fc3b0
Source feed: FDA_Inspections

> FDA inspection 1053250 of Farmaqro, S.A. de C.V., May 25, 2018. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1053250
- Company Name: Farmaqro, S.A. de C.V.
- Inspection Date: 2018-05-25
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 995560 - 2016-07-29](https://www.keypedia.com/records/fda_inspections/farmaqro-sa-de-cv/c5d89adc-1e02-4839-9ddf-65083c2054d3)
- FDA Inspection 882295 - 2014-05-16

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/nicholas-l-hunt/2f10c080-c02e-4cc3-a8a0-0675b9c4cc6d)

Company: https://www.keypedia.com/companies/farmaqro-sa-de-cv/bde3b0a4-7328-4956-8313-3013b0b91543

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c